Table 1.

Response to BT treatment, n = 24

	Baseline	6 months post	p
ACQ-5	3.3 ± 1.1	1.5 ± 1.1	<0.001a
FEV1%predicted	61.8 ± 15.9	68.7 ± 15.6	<0.05a
Salbutamol puffs/day	8 (11)	2 (2)	<0.001b
Exacerbations/6months	2.0 (2.75)	0 (1)	<0.001b
PNL mg/d n = 12	10 (7.5)	0 (4.5)	<0.005b

mean ± SD, median (IQR), PNL prednisolone, ^apaired t test, ^b Wilcoxon signed rank test